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ABSTRACT:
This study compared the cytotoxicity of IQOS aerosols to smoke from 
Marlboro Red (MR) and 3R4F reference cigarettes. Aerosol/smoke solutions were 
tested as the gas vapor phase (GVP), particulate phase (total particulate matter or 
TPM), or whole aerosol/smoke (WA), the latter being what smokers actually inhale. 
Cytotoxicities were evaluated using the LDH, MTT and neutral red uptake (NRU) 
assays in conjunction with eight different cell types, mainly from the respiratory 
system. Most test solutions did not compromise the plasma membranes of cells 
(LDH). However, mitochondrial activity (MTT) and dye uptake/lysosomal activity 
(NRU) were equally depressed by IOQS aerosols and cigarette smoke solutions at 
the high concentrations. Our NRU data with mouse 3T3 transformed fibroblasts 
were similar to those previously reported by the IQOS manufacturer and showed 
little cytotoxicity in the NRU assay. In both studies with 3T3 cells, the results were 
significantly different from 3RF4 cigarette smoke, suggesting reduced toxicity with 
IQOS. However, by expanding evaluations to a broader spectrum of cells that 
included respiratory system cells and by including higher concentrations of GVP, as
well as WA, cytotoxicity equivalent to that of Marlboro Red and 3R4F cigarettes 
was frequently observed with IQOS aerosols in the MTT and NRU assays. 
Keywords: IQOS, new tobacco products, heat-not-burn tobacco products, heated 
tobacco product, electronic nicotine delivery devices, cytotoxicity
INTRODUCTION
IQOS is a novel heat-not-burn cigarette or heated tobacco product released
by Phillip  Morris  International  (PMI)  in  2014.  Initially  sold only  to Japanese and
Italian test markets, IQOS is now available in 41 countries and in Duty Free shops
worldwide [1]. IQOS functions by heating a cast-leaf tobacco sheet, producing an
aerosol  without  burning  of  the  tobacco  [2,3].  Although  marketed  as  a  harm
reduction product, there is currently little published data on the health effects of
IQOS  aerosol.  The  manufacturer  has  written  nine  papers  evaluating  the  IQOS
system. Of these, only one focused on cytotoxicity [4].  In their study, a filter was
used to separate the gas vapor phase (GVP), which passed through the filter, from
total particulate matter (TPM). The GVP was captured in phosphate-buffered saline
solution,  while  the  TPM was  captured  on  the  filter  and  solubilized  in  dimethyl
sulfoxide  (DMSO)  [4].  IQOS  aerosols  were  tested  for  cytotoxicity  on  mouse
embryonic fibroblasts (NIH/3T3) using the neutral red uptake assay (NRU). From
these data, it  was concluded that IQOS aerosols were less cytotoxic than 3R4F
reference cigarettes. 
The  purpose  of  our  study  was  to  repeat  the  cytotoxicity  tests  done  by
Schaller et  al.  [4] and to broaden the screen to include eight cell  types,  three
cytotoxicity  assays,  and  Marlboro  Red  cigarettes  in  addition  to  3R4F  research
cigarettes.  Aerosol/smoke solutions were tested as GVP and TMP, emulating the
PMI method, and as whole aerosol/smoke (WA) collected in complete cell culture
medium, which better models user exposure. IQOS aerosols were generated using
two device cleanliness conditions, C1, in which the Holder was cleaned between
each heatstick, and C20, in which the Holder was cleaned after the 20th heatstick,
as  described  in  the  IQOS  instruction  manual.  In  a  previous  study,  a  lack  of
cleanliness in the IQOS Holder increased tobacco plug charring and polymer-film
filter melting in the C20 samples [3]. 
One cell line from the mouse and seven cell types from humans were tested.
NIH/3T3 cells are a hardy and fast-growing spontaneously transformed line of 
mouse embryonic fibroblasts, which were used in the PMI study [4].  In addition, 
we tested: (1) A549 cells isolated by others from an epithelial lung carcinoma; (2) 
BEAS-2B cells, an immortalized human bronchial epithelial cell line, often used for 
toxicity testing; (3) three primary human bronchial epithelial cell types (NHBE) 
from a child, an adult nonsmoker, and an adult smoker; (4) normal human lung 
fibroblasts (NHLF), which play a critical role in lung homeostasis, repair and 
remodeling and in previous studies have been highly sensitive to toxicant 
exposure [5,6]; and (5) H9 human embryonic stem cells (H9-hESC) which were 
used as an in vitro human embryo model. 
Three  assays  were  used  to  compare  the  cytotoxicity  of  IQOS  to  that  of
Marlboro  Red (MR) and 3R4F research cigarettes.  The assays were:  (1)  lactate
dehydrogenase (LDH), which assesses cell viability/death through leakage of the
plasma  membrane;  (2)  (3-(4,5-dimethylthiazol-2-yl)−2,5-diphenyltetrazolium
bromide  (MTT),  which  assesses  metabolic  activity  via  mitochondrial  reductase
function; and (3) NRU, which assesses dye uptake by cells and sequestration in
lysosomes. Using multiple cytotoxicity assays is important as treatments may not
all affect the same endpoint. 
MATERIALS & METHODS
Product Acquisition and Storage 
IQOS Heat-not-burn kits (Phillip Morris Products S.A. (Switzerland) and 
cartons of IQOS Marlboro (blue box) heatsticks (Phillip Morris Brands Sàrl, (Italy) 
were purchased and stored as previous described [3]. Marlboro Red cigarettes 
(Philip Morris USA Inc., Richmond, VA) were purchased at Wal-Mart. 3R4F research 
cigarettes were purchased from the University of Kentucky.
Aerosol and Smoke Solution Production
IQOS aerosols were generated under two conditions, a per-use cleaning 
protocol (C1), in which the Holder was cleaned between each heatstick, and the 
manufacturer’s recommended cleaning protocol (C20), in which the device was 
cleaned after the 20th heatstick. Smoke solutions were produced using MR and 
3R4F reference cigarettes. Two types of aerosol/smoke solutions were produced, 
fractionated, which employed a 47 mm Single Stage Filter Assembly (Savillex, 
Eden Prairie, MN) outfitted with 47 mm Emfab membrane filter (Pall Life Sciences, 
Ann Arbor, MI), and complete medium, which did not utilize a filter. All 
aerosol/smoke solutions were made using the following smoking machine 
configuration which is shown in Figure 1: the mouthpiece filter end of the IQOS 
heatstick (inserted into the IQOS Holder) was inserted into one free end of a 3/8-
inch T-Type connector (Thermo Scientific, Rochester, NY). The connector fit tightly 
and did not allow any air to be pulled into the smoking machine from outside of the
heatstick. One end of the T-connector was used to block air flow allowing for the 
activation of the puff, and the other end was either connected to the filter 
assembly (fractionated) or connected directly (complete medium) to two in-line 
glass absorption impingers, custom modified by Kimball Chase (Rockwood, TN). For
fractionated method, the first impinger contained 50 mL of ice-cold Dulbecco’s 
phosphate-buffered saline (DPBS) solution without Ca2+ and Mg2+ (Lonza, 
Walkersville, MD), while for WA, the impinger contained 50 mL of cell specific 
culture medium. For both, the second impinger contained ice-cold deionized water,
both impingers were placed into an ice bath during the course of aerosol/smoke 
collection. The impingers were then connected to a Cole-Palmer Masterflex L/S 
peristatic pump (Vernon Hills, IL) equipped with a Cole-Palmer Masterflex L/S Easy-
Load II Model 77200-52 high performance pump head and utilizing Masterflex 
Tygon E3603 (Tubing Size 36). This configuration allows for the application of the 
Health Canada standard (HCI) smoking protocol [7] which requires a 2 second puff 
that generates a total puff volume of 55 mL (27.5mL/sec), with an interpuff interval
of 30 seconds. 
Fractionated aerosols/smoke were composed of two parts, a gas vapor phase
(GVP), which was immobilized in the DPBS of impinger one, and the total 
particulate matter (TPM) which was trapped onto the Emfab membrane filters and 
desorbed by solubilization in 50 mL of dimethyl sulfoxide (DMSO) (Fisher Scientific,
Fair Lawn, NJ). Filters were changed after every two heatsticks or cigarettes. For 
IQOS, a total of 11 Emfab membrane filters were used (12 puffs per heatstick for a 
total of 21 heatsticks) and for cigarette products a total of 13 (10 puffs per 
cigarette for a total of 25 cigarettes).  All aerosol/smoke concentrations were 
expressed as a percent of solution. All solutions were aliquoted into 450 𝛍L 
volumes and placed in 0.5 mL locking lid microcentrifuge tubes (Fisher Scientific, 
Fair Lawn, NJ) to reduce headspace, and stored at -80ºC until needed. For each 
aerosol type, a total of 250 puffs were taken. Heatsticks were designed to have a 
maximum of 14 puffs but only 12 puffs were taken from each heatstick because 
this device automatically shuts off after 6 minutes of use and must be recharged. 
MR cigarettes were smoked to a butt length of 35 mm, approximately 10 
puffs/cigarette.  The overall length of the 3R4F reference cigarettes was longer 
than MR by 5 mm. The filter portion of the reference cigarette was 8 mm longer 
than that of the MR and the tobacco filled portion was 3 mm shorter thus it was 
decided to mimic puff number when smoking the reference cigarette as opposed to
butt length. 
Cell Types and Cell Culture
NIH/3T3 mouse embryonic fibroblasts (NIH/3T3) (ATCC, Manassas, VA), A-549
human lung carcinoma cells (A-549) (ATCC, Manassas, VA), normal human lung 
fibroblasts (NHLF) (Lonza, Walkersville, MD), BEAS-2B (ATCC, Manassas, VA), all 
normal human bronchial epithelial cells (NHBE) (child, adult non-smoker, and adult 
smoker) (MatTek, Ashland, MA), and H9 human embryonic stem cells (H9-hESC) 
(WiCell, Madison, WI) were maintained and cultured as described in Online 
Supplemental Figure SP1. 
Cytotoxicity Assays
For all cytotoxicity assays, lactate dehydrogenase (LDH), 3-(4,5-
dimethylthiazol-2-yl)−2,5-diphenyltetrazolium bromide (MTT), 3-amino-7dimethyl-
2-methylphenazine hydrochloride (Neutral Red dye Uptake, NRU), cells were plated
at cell-type specific densities (Online supplemental Figure SP1) and allowed to 
attach for 24 hrs. Cells were then treated with varying dilutions of 3% TPM, 30% 
GVP or 30% WA for 24 hrs (Online supplemental figure SP1). The concentration 
range was chosen to bracket doses that an IQOS user is likely to receive. After 
treatment, cells were subjected to either the LDH, MTT or NRU assays. For LDH, the
threshold of cytotoxicity was determined as a 30% increase on the y-axis between 
the lowest and highest concentration. For MTT and NRU,  the threshold of 
cytotoxicity was set at <70% of control, as determined by ISO 10993-5 [8]. Each 
experiment was performed three times. Statistical analyses of concentration-
response data were performed using Minitab 18 software (State College, PA). 
Effects of treatment were determined using a two-way ANOVA followed by Fisher’s 
post-hoc test with a Bonferroni correction (Tables 1-3 and SP 2-9). To rank cell type
sensitivity, a one-way ANOVA with Fisher’s post-hoc test was used (Table 4). 

RESULTS
Overview of Testing
The cytotoxicities of IQOS (C1 and C20) and conventional cigarettes (MR and 
3R4F) were evaluated for eight cell types using the MTT, NRU and LDH assays.  
Three types of aerosol fluid were compared for each IQOS/cigarette group. These 
were: (1) 3% TPM, (2) 3% GVP, and (3) 30% GVP. Five of the eight cell types 
(NIH/3T3, A549, NHLF, NHBE-smoker and nonsmoker) were also tested using 30% 
WA. 
Figure 2 shows representative concentration-response graphs for 30% WA 
using NHBE-nonsmoker cells. In the LDH assay (Figure 2 A), none of the treatments
produced cytotoxicity, indicating cell plasma membrane integrity was not 
compromised.  In the MTT assay, the aerosols from conventional cigarettes were 
more cytotoxic than those from IQOS at the lower concentrations, but 
cytotoxicities were equivalent at 10 and 30% (Figure 2 B). In the NRU assay, 
cytotoxicities were similar for all four treatment groups (Figure 2 C). 
Concentration-response curves for all aerosol treatments and cell types are 
presented in supplemental data SP2-SP9 for each cytotoxicity assay. 
Tables 1-3 report amalgamated data from the LDH, MTT and NRU assays, 
respectively.  Data presented in these tables are the means of the percent of 
control for the highest tested concentration for each treatment and cell type. 
Statistical comparisons were done between each group and the 3R4F group, and 
treatments that were significantly different from the 3RF4 cigarettes are indicated 
by asterisks. Pale red boxes indicate that a treatment was cytotoxic (i.e., an IC70 or 
>30% reduction from the untreated control was observed), and bright red boxes 
indicate IQOS values that were not significantly different from the 3R4F group. 
Green boxes indicate a lack of cytotoxicity. Pale blue boxes indicate cell type(s) 
that had statistical differences between C1 and C20 for 3% TPM and the bright blue
box indicates cell type(s) that had statistical differences between C1 and C20 for 
3% TPM and 30% WA. The next sections summarize the data for all treatments and
cell types.
LDH Assay
 All but four IQOS treatments and most conventional cigarette treatments 
were not cytotoxic with the LDH assay (Table 1). The most noteworthy results 
were: (1) for TPM, only five of 40 conventional cigarette treatments were cytotoxic 
(30% change from untreated control); (2) for 3% GVP, only two of 40 conventional 
cigarette treatments were cytotoxic; (3) for 30% GVP, 12 of 40 treatments were 
cytotoxic, and this included IQOS treatments for NHLF and BEAS-2B cells; and (4) 
for WA, cytotoxicities were only seen in six of 20 conventional cigarette treatments
(NIH/3T3, A549 and NHLF). Two-way ANOVA results showed no statistical 
significance when comparing the effects of aerosol/smoke treatment and 
concentration on percent of control values. These data show that most treatments 
were not making cell plasma membranes leaky and killing cells. Additional assays 
were next used to determine if metabolism (MTT) and dye uptake and lysosomal 
integrity (NRU) were affected by treatments. 
  MTT Assay
 Most 3% TPM test samples (33 of 40) were cytotoxic in the MTT assay (Table
2). Both conventional cigarettes were cytotoxic to all eight cell types, and IQOS C1 
and C20 were cytotoxic to NIH/3T3, NHLF, BEAS-2B, and H9-hESC.  The 3% TPM 
results for A549 (C1), NIH/3T3 (C1 and C20) and H9-hESC (C1 and C20) were not 
significantly different from 3R4F cigarettes (Table 2 red boxes), indicating that for 
these comparisons, IQOS and 3R4F cigarettes were equivalent in cytotoxicity. 
The 3% GVP treatments were in general not cytotoxic.  For conventional 
cigarette treatments, cytotoxicity was only observed for four cell types (NIH/3T3, 
NHLF, NHBE-child 3R4F and BEAS-2B MR), and IQOS treatments were not cytotoxic 
to any cell type.  In contrast, 30% GVP was cytotoxic to almost all cells, the only 
exceptions being IQOS C1 and C20 for NIH/3T3 and A549 cells.  Results with NHLF, 
NHBE-child (C20), and BEAS-2B were not significantly different from those with the 
3RF4 group (Table 2 red boxes). 
30% WA, which was tested with the five most relevant cell types, was 
generally cytotoxic.  WA from both conventional cigarettes was cytotoxic to all cell 
types, and IQOS WA was cytotoxic to three of five cell types (NIH/3T3, NHLF, and 
NHBE-nonsmoker). The effect of WA C1 and C20 on NHBE-nonsmoker was not 
statistically different from 3R4F (Table 2 red boxes).  
The MR and 3R4F groups were not statistically different from each other for 
any cell type or treatment group except NHLF exposed to 3% GVP, for which MR 
was significantly more cytotoxic than 3R4F (p < 0.003125).  There were no 
significant differences between C1 and C20 IQOS for any cell type or treatment 
group.
NRU Assay
For 3 % TPM, conventional cigarettes produced a cytotoxic effect for all eight
cell types, while IQOS was cytotoxic to all cell types except NHBE-nonsmoker and 
NHBE-child. In some cases, either IQOS C1 (NIH 3T3, A549, NHBE-Smoker) or IQOS 
C20 (BEAS-2B) were cytotoxic.  Among IQOS sensitive cells, A549 (C1) and H9-
hESC (C1 and C2) were not statistically different from 3R4F treated cells (Table 3 
red boxes). 
3% GVP from IQOS was not cytotoxic to any cell type, while 3% GVP from 
cigarettes was cytotoxic only to NHLF. 30% GVP from conventional cigarettes was 
cytotoxic to all eight cell types, and IQOS was toxic to all but A549 cells. Of the 
seven cell types affected by IQOS, six were not significantly different from 3R4F 
(Table 3 red boxes). Only NIH 3T3 cells, the cell type tested previously by Schaller 
et al. [4], were significantly less affected by IQOS C1 and C20 than by the 3RF4 
research cigarettes.  
All 30% WA IQOS and conventional cigarette exposures were cytotoxic. For 
IQOS, the NBHE-smoker and NBHE-nonsmoker groups were not statistically 
different from the 3R4F group (Table 3 red boxes). 
MR was significantly more cytotoxic than 3RF4 for the NHLF. Significant 
differences between the IQOS C1 and IQOS C20 groups were observed for TPM 
treatments of A549, NHLF, and NHBE-smoker (pale blue boxes in Table 3), and NIH/
3T3 had significant differences for TPM and WA treatments (bright blue box in 
Table 3).  
Cell Type Sensitivity Hierarchy
Using one-way ANOVA analysis of 30% GVP data, cell types were ranked for 
overall sensitivity to aerosol/smoke exposure. Table 4 presents the means of three 
experiments for each cell type in the MTT and LDH assays and their sensitivity to 
treatment (grouping) based on the ANOVA analysis. In grouping, cells with the 
different letters were significantly different from each other. Cells were ranked in 
increasing sensitivity from A through C/D. For MTT data, A549 and NIH/3T3 were 
the least sensitive, the three NHBE were in the midrange, and NHLF, BEAS-2B and 
H9-hESC were the most sensitive to treatment (Table 4 MTT). 
For NRU data, A549 and NHBE-child cells were the least affected by 
exposure, NHBE-nonsmoker, NHBE-smoker, and NIH/3T3 were mid-range, and 
NHLF, BEAS-2B and H9-hESC were the most sensitive (Table 4 NRU). 
To determine an overall hierarchy of sensitivity, the mean values from MTT 
and NRU were averaged showing that A549 and NIH/3T3 were the least sensitive, 
the three NHBE were in the midrange, and NHLF, BEAS-2B and H9-hESC were the 
most sensitive (Table 4 Averaged). 
DISCUSSION
The cytotoxicities of conventional cigarette smoke and IQOS aerosols were 
compared in a comprehensive screen using eight cell types, three endpoint assays,
and various components of smoke/aerosols. NIH/3T3 cells and the NRU assay were 
chosen to allow direct comparison to a prior study on IQOS and 3R4F cigarettes
[4]. Additional cells from respiratory tissue were included as relevant models for 
inhalation toxicology, and H9-hESC were studied to determine how embryos and 
hence prenatal development may be affected by IQOS.  Fractions of smoke/aerosol
(TMP and GVP) were compared, as was done previously [4], and whole aerosol and 
smoke, which is what IQOS users actually inhale, were also studied.  Our five most 
significant observations were: (1) IQOS exposure did not lead to cell death (LDH) in
most trials but did adversely affect critical cellular functions (MTT & NRU); (2) 
mouse 3T3 fibroblasts were not significantly affected by IQOS aerosol in the NRU 
assay, as reported previously by the manufacturer [4]; (3) for some cell types 
(bright red boxes in Tables 2 and 3), IQOS aerosol and 3R4F smoke were equally 
cytotoxic for comparisons made at the high concentrations; (4) cell types varied in 
their sensitivity to IQOS aerosol and cigarette smoke with cells from human 
embryos and the respiratory system usually being more sensitive than NIH/3T3, 
which were used in a prior study [4], and cancer cells (A549); (5) results for IQOS 
C1 and C20 were similar for the MTT assay, but NRU analysis showed differences 
between the treatments in A549 (C1 > C20), NHBE-smoker (C1 > C20), and NHLF 
(C1 < C20) for TMP and in NIH/3T3 for both TPM (C1 > C20) and WA (C1 < C20); 
and (6) in all but one case (NHLF at 3% GVP), MR had equivalent cytotoxicities to 
3R4F cigarettes.
LDH analysis showed that cells were generally not killed by IQOS, MR or 3R4F
treatments.  Notable exceptions were the NHLF and BEAS-2B cells, which were 
affected by all 30% GVP treatments. MTT and NRU data showed that IQOS C1 and 
C20 did have adverse effects on cell metabolism and dye uptake. These data agree
with another study that investigated the effects of IQOS aerosols using an air-liquid
interface (ALI) system and found that exposure did not lead to cell death but rather
adversely affected metabolic activity [9]. Our MTT data are also in agreement with 
a recent study showing that IQOS had similar effects to cigarette smoke when 
tested with BEAS2-B cells, although these authors found that IQOS had a stronger 
effect in the LDH assay than we observed [23].  Comparison of our MTT and NRU 
data showed that both the 3% TPM and 30% GVP treatments were cytotoxic and 
that the response to GVP was concentration dependent. For WA, both IQOS and 
conventional cigarettes were cytotoxic to all five cell types with which they were 
tested. IQOS Holder cleanliness did not significantly affect the outcome for the MTT
assay but did sometimes produce a significant effect in the NRU assay, with C20 
usually being more cytotoxic than C1. In general, MR and R3F4 smoke was 
equivalent in both the MTT and NRU assays.  
In a prior study on IQOS cytotoxicity using NIH/3T3 cells [4], the equivalent of
IQOS C20 produced very little effect using the NRU, in agreement with our 
observations (e.g. 85% for 3% TPM and 88% for 3% GVP), and these effects in both
studies were significantly different from 3RF4 cigarette smoke, suggesting reduced
toxicity with IQOS. However, by expanding evaluations to a broader spectrum of 
cells that included six types of respiratory cells and by including higher 
concentrations of GVP as well as WA, it was evident that cytotoxicity was 
frequently observed with IQOS aerosols. One of the most important observations in
our study is the finding that in a number of instances, there was no significant 
difference in toxicity between IQOS and 3R4F treatments. 
A hierarchy of cell sensitivity was created for the MTT and NRU assays and 
averages of these assays based on the 30% GVP data (Table 4). The most sensitive
respiratory cells were NHLF, which play a vital role in maintaining lung health by 
producing the extracellular matrix, which is essential for support and normal lung 
function [10]. H9-hESC were also in the most sensitive group suggesting that IQOS 
may not be an appropriate product for pregnant women. All three primary, 
untransformed NHBE cell types (smoker, nonsmoker, and child) were in the 
midrange of sensitivity. Within the bronchial epithelial group, the NHBE cells from 
the smoker were always more sensitive than those from the adult non-smoker or 
child. While this hierarchy is based on cells from only one individual per group, 
these data suggest that the respiratory epithelium from a smoker is less able to 
tolerate IQOS aerosol exposure than similar cells from non-smokers and children. 
NIH/3T3 (mouse embryonic fibroblast) and A549 cells (lung carcinoma) were the 
least sensitive to IQOS treatment, indicating they may not be the best cell choice 
for testing tobacco products that are inhaled. These data reaffirm that different cell
types should be evaluated in cytotoxicity testing and show that cells from the 
human respiratory system are more sensitive to IQOS treatment than mouse 3T3 
cells, which were used in a prior study [4]. 
Although IQOS aerosol did not kill cells, it did have adverse effects in the MTT
and NRU assays. These assays examine different endpoints and provide 
information on how IQOS aerosol affects cellular functions. A decline in 
mitochondrial reductase activity, as measured by the MTT assay, can lead to 
metabolic dysfunction, causing increased ROS production and oxidative damage
[11-13].  This dysfunction can adversely affect redox signaling, which regulates cell
death and survival pathways [12,14]. Decreases in reductase activity also lowers 
ATP production by oxidative phosphorylation [14-17], leading to compromised cell 
health. Dysregulation of succinate dehydrogenase, a key mitochondrial reductase 
and tumor suppressor, can lead to promotion of malignant cancers [18-20]. 
NRU data demonstrated that IQOS adversely effected dye uptake through 
the plasma membrane and/or maintenance of an acidic lysosomal pH. Proper pH 
gradients across lysosomal membranes require ATP production [21], thus our 
results with the NRU assay would be consistent with the observed decline in 
mitochondrial reductase (MTT assay). While the MTT and NRU assays gave similar 
results in our study, cytotoxicity was observed somewhat more frequently with the 
NRU assay (18 out of 32 trials vs 14 out of 32 trials for MTT), suggesting that NRU 
may be somewhat more sensitive than the MTT assay and may be a better choice 
if only one assay is used.  Lysosomes play a critical role in cellular homeostasis by 
recycling of macromolecules, but when damaged, hydrolases leak out leading to 
lysosomal cell death (LCD) [22]. While we did not observe cell death in most trials 
(LDH), the NRU data suggest that death would have occurred had incubations been
longer.
The equivalent cytotoxicity observed with IQOS aerosol and 3R4F research 
cigarette smoke and the sensitivity of human bronchial epithelial cells and lung 
fibroblasts to IQOS aerosols is a concern. While our data cannot be directly 
extrapolated to human health, they clearly show a need for additional studies on 
IQOS products. 
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Figure 1: Diagram showing the configuration of the smoking machine used to 
make TPM, GVP, and WA. 
Figure 2. Representative concentration-response graphs for NHBE-nonsmoker 
treated with 30% WA.  (A) LDH, (B) MTT, and (C) NRU assays. For all graphs x-
axis = concentration in % solution, y-axis = percent of experimental control. 
Blue = C1, green = C20, red = Marlboro Red, purple = 3R4F. Each line 
represents the mean ± SD of three independent experiments.
Table 1: LDH Assay1
LDH
 
3%
TPM
3%
GVP
30%
GVP
30%
WA
NIH/3T3
C1 44±3 48±2 50±4 12±2
C20 41±1 42±3 53±4 11±2
MR 41±0 45±1 64±4 46±3
3R4
F 39±1 44±1 65±4 31±3
A549
C1 17±3 18±2 17±2 13±1
C20 17±1 17±1 19±1 14±0
MR 16±1 16±1 15±1 27±1
3R4
F 17±1 16±2 16±1 28±2
NHLF
C1 14±2 21±2 43±1 9±1
C20 16±1 20±2 44±3 10±1
MR 28±1 36±2 37±3 57±4
3R4
F 19±5 26±4 32±2 60±5
NHBE-Smoker
C1 16±4 16±3 17±2 16±5
C20 10±1 18±1 21±2 13±1
MR 31±1 17±2 31±1 24±6
3R4
F 27±4 19±2 31±3 19±4
NHBE-
Nonsmoker
C1 9±1 18±5 16±1 17±3
C20 11±2 15±1 20±2 16±5
MR 23±3 12±0 23±4 18±4
3R4
F 27±1 19±1 22±2 20±2
NHBE-Child
C1 8±1 16±1 20±3 n/a
C20 11±1 12±1 23±1 n/a
MR 25±1 14±1 33±4 n/a
3R4
F 21±1 15±1 31±6 n/a
BEAS-2B
C1 2±1 2±1 35±4 n/a
C20 2±1 2±1 45±3 n/a
MR 8±1 15±1 31±4 n/a
3R4
F 6±1 3±1 37±3 n/a
H9-hESC
C1 26±3 23±1 20±2 n/a
C20 27±4 25±1 23±4 n/a
MR 29±1 26±1 28±1 n/a
3R4
F 33±5 24±1 46±3 n/a
1LDH cytotoxicity data for IQOS and conventional cigarettes. Columns show the 
four types of aerosol/smoke solution that were tested. Rows show the cell types 
and product source of the aerosol/smoke solutions. Data are the means ± standard
deviations of three experiments at the highest concentration tested for each type 
of aerosol/smoke solution. C1, C20, and MR red values were statistically compared 
to 3R4F using two-way ANOVAs, TPM = total particulate matter of fractionated 
aerosol/smoke; GVP = gas vapor phase of fractionated aerosol/ smoke; WA = 
whole aerosol/smoke captured in culture medium. C1 = IQOS cleaned after each 
use; C20 = IQOS cleaned after 20 uses. MR = Marlboro Red cigarettes; 3R4F = 
reference cigarette. Pale red boxes = toxicity values < 70% of control, green 
boxes = toxicity values ≥ 70%, bright red boxes = IQOS and R3R4F means were 
not significantly different.
Table 2 MTT 
Assay 1 MTT
   
3%
TPM
3%
GVP
30%
GVP
30%
WA
NIH/3T3
C1 61±9 75±12 87±5* 41±6*
C20 51±20 91±8* 104±14* 43±6*
MR 30±2 66±5 44±4 18±2
3R4
F 49±4 68±6 35±5 8±3
A549
C1 59±24 97±4 88±4* 75±6*
C20 70±19* 95±3 93±3* 73±3*
MR 46±7 87±4 49±1 11±1
3R4
F 41±2 100±2 46±4 9±1
NHLF
C1 38±9* 84±16* 7±2 62±4*
C20 47±3* 93±10* 7±2 67±5*
MR 18±2 23±4* 5±3 5±1
3R4
F 19±4 51±6 11±3 5±1
NHBE-Smoker
C1 77±5* 108±13 53±18* 83±4*
C20 81±14* 102±3 41±17* 96±6*
MR 35±6 94±3 11±1 29±2
3R4
F 33±5 100±4 8±1 25±1
NHBE-
Nonsmoker
C1 77±3* 107±5 54±22* 30±5
C20 81±12*
117±1
8 47±22* 29±2
MR 35±7 96±10 15±4 35±21
3R4
F 33±5
104±2
2 11±1 16±10
NHBE-Child
C1 90±35* 80±19 50±14* n/a
C20 86±6* 94±17 44±9 n/a
MR 50±15 87±15 16±1 n/a
3R4
F 44±22 59±13 12±2 n/a
BEAS-2B C1 40±6* 89±6* 12±5 n/a
C20 52±6* 88±21 9±10 n/a
*
MR 7±1 24±7 2±0 n/a
3R4
F 6±1 70±14 2±0 n/a
H9-hESC
C1 17±5 86±8 11±3* n/a
C20 11±5 102±11 13±3* n/a
MR 17±10 78±8 3±2 n/a
3R4
F 12±5 91±20 3±1 n/a
1MTT cytotoxicity data for IQOS and conventional cigarettes. Columns show the 
four types of aerosol/smoke solution that were tested. Rows show the cell types 
and product source of the aerosol/smoke solutions. Data are the means of three 
experiments at the highest concentration tested for each type of aerosol/smoke 
solution. C1, C20, and MR red values were statistically compared to 3R4F using 
two-way ANOVA, * = adjusted p < 0.003125. TPM = total particulate matter of 
fractionated aerosol/smoke; GVP = gas vapor phase of fractionated aerosol/ 
smoke; WA = whole aerosol/smoke captured in culture medium. C1 = IQOS 
cleaned after each use; C20 = IQOS cleaned after 20 uses. MR = Marlboro Red 
cigarettes; 3R4F = reference cigarette. Pale red boxes = toxicity values < 70% of 
control (considered cytotoxic), green boxes = toxicity values ≥ 70% (not 
cytotoxic), bright red boxes = IQOS and R3R4F means were not significantly 
different. * indicates the result was significantly different than 3R4F. 
             Table 3 
NRU Assay1
Neutral Red
   
3%
TPM
3%
GVP
30%
GVP
30%
WA
NIH/3T3
C1 63±8* 80±6 52±4* 58±1*
C20 85±4* 88±5* 59±5* 39±1*
MR 24±3 83±7 11±2 15±2
3R4
F 30±4 75±6 13±1 10±4
A549
C1 50±5 106±4 89±9* 63±6*
C20 79±18 105±21 86±5* 65±4*
MR 46±5 93±5 43±4 23±3
3R4
F 60±18 95±2 39±7 22±2
NHLF
C1 62±9* 88±3* 20±3 42±2*
C20 47±6* 91±2* 22±7 46±3*
MR 17±3 34±4* 15±1 7±1
3R4
F 28±8 59±4 17±2 7±1
NHBE-Smoker
C1 68±15* 81±15 49±16 38±7
C20 96±1* 80±7 48±7 32±5
MR 40±14 95±5 36±8 37±4
3R4
F 35±2 78±10 45±8 39±1
NHBE-
Nonsmoker
C1 109±9* 95±14 66±6 43±4
C20 77±8* 91±15 43±6 54±4
MR 40±3 88±4 47±27 50±4
3R4
F 33±5 77±5 46±8 56±2
NHBE-Child
C1 83±14 98±9 62±7 n/a
C20 70±12 100±19 69±13 n/a
MR 47±3 79±6 54±7 n/a
3R4
F 47±8 82±5 69±10 n/a
BEAS-2B
C1 72±2* 78±15 17±4 n/a
C20 59±1* 83±5 16±4 n/a
MR 45±13 73±14 19±7 n/a
3R4
F 35±8 74±4 13±2 n/a
H9-hESC
C1 24±9 96±15 22±9 n/a
C20 27±14 109±22 31±8 n/a
MR 23±11 90±24 12±6 n/a
3R4
F 19±2
105±1
5 22±4 n/a
1NRU cytotoxicity data for IQOS and conventional cigarettes. Columns show the 
four types of aerosol/smoke solution that were tested. Rows show the cell types 
and product source of the aerosol/smoke solutions. Data shown are the means of 
three experiments at the highest concentration tested for each type of 
aerosol/smoke solution. C1, C20, and MR red values were statistically compared to 
3R4F using a two-way ANOVA, * = adjusted p < 0.003125. TPM = total particulate 
matter of fractionated aerosol/smoke; GVP = gas vapor phase of fractionated 
aerosol/ smoke; WA = whole aerosol/smoke captured in culture medium. C1 = 
IQOS cleaned after each use; C20 = IQOS cleaned after 20 uses.  MR = Marlboro 
Red cigarettes; 3R4F = reference cigarette. Pale red boxes = toxicity values < 
70% of control (considered cytotoxic), green boxes = toxicity values ≥ 70% of the 
control (non-cytotoxic), bright red boxes = IQOS and R3R4F means are not 
significantly different. Bright blue box = cell type(s) that had statistical differences 
between C1 and C20 for 3% TPM and 30% WA. Pale blue boxes = cell type(s) that 
had statistical differences between C1 and C20 for 3% TPM. * indicates the result 
was significantly different than 3R4F.
Table 4: Cell Type Sensitivity Hierarchy1
MTT NRU Averag
ed1
Cell 
Type
Mean
(SD) 
Groupin
g2
Cell 
Type
Mean
(SD) 
Groupin
g2
Cell 
Type
Mean 
(SD) 
Groupin
g2
A549 68.83
(24.9
4)
A A549 64.17
(26.9
2)
A A549 66.50
( 24.16)
A
NIH/
3T3
67.67
(33.2
7)
A NHBE-
C
63.25
(7.14
)
A NIH/
3T3
50.84
(32.77)
A, B
NHBE-
NS
30.42
(21.9
)
     B NHBE-
NS
56.08
(10.4
7)
A, B NHBE-
C
47.38
(22.19)
   B, C
NHBE-
C
31.5
(19.2
8)
     B NHBE-
S
44.5
(5.92
)
     B, C NHBE-
NS
43.25
(18.79)
         C
NHBE-
S
28.42
(22.2
3)
     B NIH/
3T3
34
(25.2
9)
          C NHBE-
S
36.46
(17.39)
         C
NHLF 7.33
(2.52
)
          C H9 21.17
(7.76
)
             
D
H9 14.42
(9.78)
          D
H9 7.67
(5.26
)
          C NHLF 18.5
(3.11
)
             
D
NHLF 12.92
(6.44)
          D
B2B 6.25
(5.06
)
          C B2B 16.33
(2.5)
             
D
B2B 11.29
(6.50)
          D
1Cell type treatment sensitivity hierarchy. Using one-way ANOVA with Fisher post-
hoc test, cells were ranked based on mean percent of control values of three 
experiments vs. cell type. The grouping column shows the results of the ANOVA. 
Means that do not share a letter (Groupings) are significantly different. Tables were
arranged from least sensitive to most sensitive for MTT and NRU data and the 
average of MTT and NRU means.
Supplementary Material and Methods and Figures
SP1: Materials and Methods:
Cell Culture
NIH/3T3 mouse embryonic fibroblasts (ATCC, Manassas, VA) on Nunc™ Cell 
Culture Treated EasYFlasks™ (T-25 flasks) (Roskilde, Denmark) were maintained in
Dulbecco’s Modified Eagle’s Medium supplemented with 10% bovine calf serum 
(ATCC, Manassas, VA) with twice weekly medium changes until cells were ≤ 80% 
confluent. To subculture or prepare for experiments, cells were rinsed in 0.25% 
trypsin-EDTA (1x) (Gibco, Grand Island, NY) then detached using 0.25% trypsin-
EDTA (1x) for 5 min at 37ºC.  Trypsin was neutralized by adding complete growth 
medium in double the volume of trypsin, and cell suspensions were aliquoted into 
appropriate culture vessels. For subculture, cells were plated at 4 x 103 cells/cm2 (1
x 105 cells/T-25 flask); for cytotoxicity experiments, cells were plated at 2.5 x 103 
cells/well (of a 96-well plate, Falcon, Corning, Durham, NC). 
H9-hESC (WiCell, Madison, WI), on 6-well tissue culture treated plates 
(Falcon, Corning, Durham, NC) coated in Matrigel Matrix (Corning, Bedford, MA), 
were maintained in mTeSRTM1 medium (Stem Cell Technologies, Vancouver, BC, 
Canada) with daily medium changes until cells were when 60–80% confluent. For 
subculture and experimental preparation of cells, wells were washed in DPBS, 
colonies were then detached using ReLeSRTM enzyme-free passaging reagent (Stem
Cell Technologies, Vancouver, BC, Canada) for 5 min at room temperature, 
mTeSRTM1 medium was added and the plate gently tapped to release colonies.  
Cells were transferred to a 15 mL conical tube (Falcon, Corning, Durham, NC), the 
colonies were broken up by pipetting gently, cell suspensions were aliquoted into 
appropriate culture vessels. For subculture, cells were plated at 350 colonies/well 
(6-well plate); for cytotoxicity experiments, cells were plated at 150 colonies/well 
(96-well plate). 
NHLF (Lonza, Walkersville, MD) on Nunc™ Cell Culture Treated EasYFlasks™ 
(T-25 flasks) were maintained in FGMTM-2 Growth Medium (Fibroblast basal medium
supplemented with FGMTM-2 SingleQuotsTM) (Lonza, Walkersville, MD) with medium 
changes occurring every other day until cells reached a confluence of 70-80%. For 
subculture/experimental preparation, cells were washed in HEPES buffered saline 
solution, then detached using 0.25 mg/mL trypsin/EDTA solution for 2 min at 37ºC. 
Trypsin was neutralized with TNS (Trypsin neutralizing solution) (Lonza, 
Walkersville, MD), and cells were transferred to a 15 mL conical tube, rinse flask 
with HEPES and add to cell solution, centrifuge cells at 220xg for 5 min, discard 
supernatant, resuspend cells in culture medium, and aliquot cell suspensions into 
appropriate culture vessels. For subculture, cells were seeded at 2.5x103 cells/cm2 
(6.25x104 cells/ T-25 flask); for cytotoxicity experiments cells were plated at 5x103 
cells/well (96-well plate). 
A549 human lung carcinoma cells (ATCC, Manassas, VA) on Nunc™ Cell 
Culture Treated EasYFlasks™ (T-25 flasks) were maintained in F-12K medium 
supplemented with 10% fetal bovine serum (ATCC, Manassas, VA). Medium was 
changed every other day until cells reached a confluence ≤80%. Subculture/ 
experimental preparation, rinse cells in 0.25% Trypsin-EDTA (1x), detach using 
0.25% Trypsin-EDTA (1x) for 2 min at 37ºC, neutralize trypsin by adding fetal 
bovine serum (Sigma Aldrich, St. Louis, MO) in double the volume of trypsin, 
transfer cell solution to a 15 mL conical tube, centrifuge cells at 220xg for 5 min, 
discard supernatant, resuspend cells in culture medium, and aliquot cell 
suspensions into appropriate culture vessels. For subculture, cells were seeded at 
2.5x103 cells/cm2 (6.25x104 cells/T-25 flask); for cytotoxicity experiments cells 
were plated at 2.5x103 cells/well (96-well plate).
BEAS-2B (ATCC, Manassas, VA) on Nunc™ Cell Culture Treated EasYFlasks™ 
(T-25 flasks) coated with 0.1 mg/mL Fibronectin, 0.03 mg/mL bovine collagen type 
I, and 0.01 mg/mL bovine serum albumin (Sigma Aldrich, St. Louis, MO) in BEBMTM 
basal medium (Lonza, Walkersville, MD) were maintained in BEGMTM (Bronchial 
epithelial basal medium supplemented with BEGMTM BulletKitM) (Lonza, 
Walkersville, MD) with every other day medium changes until cells reach a 
confluence of ≤80%. Subculture/ experimental preparation, cells are detached 
using 0.25% Trypsin-EDTA (1x) supplemented with 0.5% polyvinylpyrrolidone 
(Sigma Aldrich, St. Louis, MO) for 2 min at 37ºC, neutralize trypsin by adding 
complete growth medium in double the volume of trypsin, transfer cell solution to 
a 15 mL conical tube, centrifuge cells at 125xg for 5 min, discard supernatant, 
resuspend cells in culture medium, and aliquot cell suspensions into appropriate 
culture vessels. For subculture, cells were seeded at 2.25x103 cells/cm2 (5.625x104 
cells/T-25 flask); for cytotoxicity experiments cells were plated at 3x103 cells/well 
(96-well plate).
For all NHBE cell types (child, adult non-smoker, and adult smoker) on 
Nunc™ Cell Culture Treated EasYFlasks™ (T-25 flasks) were maintained NHBE-GM, 
growth medium, (NHBE-BM, basal medium, supplemented with NHBE-GS, growth 
serum, and NHBE-HCS, hydrocortisone) with medium changes occurring every 
other day until cells reached a confluence ≤80%. Subculture/ experimental 
preparation, rinse cells in DPBS, detach using 0.25% Trypsin-EDTA (1x) for 10 min 
at 37ºC, neutralize trypsin by adding STI (soybean trypsin inhibitor solution, 250
𝛍g/mL), transfer cell solution to a 15 mL conical tube, rinse flask with DPBS and 
add to contents of conical vial, centrifuge cells at 150xg for 10 min, discard 
supernatant, resuspend cells in culture medium, and aliquot cell suspensions into 
appropriate culture vessels. For subculture, cells were seeded at 3.3x103 cells/cm2 
(8.25x104 cells/T-25 flask); for cytotoxicity experiments cells were plated at 5x103 
cells/well (96-well plate).
All cultures were maintained at 37ºC with 5% CO2, and 95% relative humidity. For 
sub-culturing and experiments, cell counts were performed using a Nikon Eclipse 
TS100 Inverted Microscope (Tokyo, Japan) and a hemocytometer (Hausser 
Scientific, Horsham, PA), with the exception of the H9-hESC. For H9, colony counts 
were performed using a 96-plate following the protocol as described in the 
mTeSR1 product manual. 
Cytotoxicity Assays
MTT
Thiazolyl Blue Tetrazolium Blue (MTT) (Sigma Aldrich, St. Louis, MO) solution was 
prepared at a concentration of 5 mg/mL in DPBS with Ca2+ and Mg2+ (Lonza, 
Walkersville, MD). After 24-hour of treatment, 20 µL of MTT was added to each well
of cells and blank wells and incubated at 37ºC, 5% CO2, and 95% relative humidity
for 2 hours. After incubation, MTT solution was removed and 100 µL of DMSO was 
added to each well. Solutions were gently mixed by pipetting. Plates were read 
using an Epoch microplate spectrophotometer (BioTek, Winooski, VT) at λ=570nm.
Neutral Red
Neutral Red biological stain (Acros Organics, NJ) was diluted in DPBS without Ca2+ 
and Mg2+ to a stock concentration of 4mg/mL. The stock was light shielded and 
stored at room temperature until needed. Neutral Red stock was further diluted to 
a working concentration of 40 µg/mL in cell type specific culture medium. Solutions
were filtered and incubated with at 37°C overnight prior to addition to cells 
(neutral red solutions were prepared at the time of treatment). After 24-hour 
treatment, medium was removed from all wells and 150 µL of incubated/filtered, 
Neutral Red solution was added to each control treatment, and blank well. Plates 
were incubated at 37ºC, 5% CO2, and 95% relative humidity for 2 hours. During 
incubation a lysis solution of 50% ethanol, 49% dH2O and 1% acetic acid (Fisher 
Scientific, Fair Lawn, NJ) was prepared. After incubation Neutral Red solution was 
removed, each well was rinsed with 100 µL DPBS without Ca2+ and Mg2+, and 150 
µL of lysis solution was added to each well and gently pipetted, ensuring no 
bubbles were present. Plates were read using an Epoch microplate 
spectrophotometer at λ=540nm.
LDH
Pierce LHD Cytotoxicity Assay Kit (Pierce Biotechnology, Rockford, IL) was 
used to determine LDH values. All reagents were prepared, experiments were 
performed, and values were calculated according to the manufacturer’s protocol. 
SP2. Cytotoxicity data for NIH/3T3 mouse embryonic fibroblasts. MTT, NRU, 
and LDH for 3% TPM, 3% GVP, 30% GVP, and 30% WA concentration- response 
curves. For all graphs, the x-axis = concentration in % solution, y-axis = 
percent of untreated control. Blue = IQOS C1, green =IQOS C20, red = 
Marlboro Red (MR), purple = 3R4F, black = DMSO (for TPM) or PBS (for GVP) 
control, orange = room air control. Each line represents the average of three 
experiments ± SD.
SP3. Cytotoxicity data for A-549 human lung adenocarcinoma cells. MTT, 
NRU, and LDH for 3% TPM, 3% GVP, 30% GVP, and 30% WA concentration- 
response curves. For all graphs, the x-axis = concentration in % solution, y-
axis = percent of untreated control. Blue = IQOS C1, green =IQOS C20, red
= Marlboro Red (MR), purple = 3R4F, black = DMSO (for TPM) or PBS (for 
GVP) control, orange = room air control. Each line represents the average 
of three experiments ± SD.
SP4. Cytotoxicity data for NHLF. MTT, NRU, and LDH for 3% TPM, 3% GVP, 
30% GVP, and 30% WA concentration- response curves. For all graphs, the x-
axis = concentration in % solution, y-axis = percent of untreated control. 
Blue = IQOS C1, green =IQOS C20, red = Marlboro Red (MR), purple = 3R4F,
black = DMSO (for TPM) or PBS (for GVP) control, orange = room air control. 
Each line represents the average of three experiments ± SD.
SP5. Cytotoxicity data for NHBE-Smoker. MTT, MTT, NRU, and LDH for 3% 
TPM, 3% GVP, 30% GVP, and 30% WA concentration- response curves. For
all graphs, the x-axis = concentration in % solution, y-axis = percent of 
untreated control. Blue = IQOS C1, green =IQOS C20, red = Marlboro Red
(MR), purple = 3R4F, black = DMSO (for TPM) or PBS (for GVP) control, 
orange = room air control. Each line represents the average of three 
experiments ± SD.
SP6. Cytotoxicity data for NHBE-Non-smoker. MTT, NRU, and LDH for 3% 
TPM, 3% GVP, 30% GVP, and 30% WA concentration- response curves. 
For all graphs, the x-axis = concentration in % solution, y-axis = percent 
of untreated control. Blue = IQOS C1, green =IQOS C20, red = Marlboro 
Red (MR), purple = 3R4F, black = DMSO (for TPM) or PBS (for GVP) 
control, orange = room air control. Each line represents the average of 
three experiments ± SD.
SP7. Cytotoxicity data for BEAS-2B lung epithelial cells. MTT, NRU, and 
LDH for 3% TPM, 3% GVP, 30% GVP, and 30% WA concentration- 
response curves. For all graphs, the x-axis = concentration in % 
solution, y-axis = percent of untreated control. Blue = IQOS C1, green 
=IQOS C20, red = Marlboro Red (MR), purple = 3R4F, black = DMSO 
(for TPM) or PBS (for GVP) control, orange = room air control. Each line
represents the average of three experiments ± SD.
SP8. Cytotoxicity data for NHBE-Child. MTT, NRU, and LDH for 3% TPM, 3% 
GVP, 30% GVP, and 30% WA concentration- response curves. For all 
graphs, the x-axis = concentration in % solution, y-axis = percent of 
untreated control. Blue = IQOS C1, green =IQOS C20, red = Marlboro Red 
(MR), purple = 3R4F, black = DMSO (for TPM) or PBS (for GVP) control, 
orange = room air control. Each line represents the average of three 
SP9. Cytotoxicity data for H9-hESC. MTT, NRU, and LDH for 3% TPM, 3% 
GVP, 30% GVP, and 30% WA concentration- response curves. For all 
graphs, the x-axis = concentration in % solution, y-axis = percent of 
untreated control. Blue = IQOS C1, green =IQOS C20, red = Marlboro Red
(MR), purple = 3R4F, black = DMSO (for TPM) or PBS (for GVP) control, 
orange = room air control. Each line represents the average of three 
